A phase II study of gemcitabine plus carboplatin in platinum-sensitive, recurrent ovarian carcinoma


Kose M. F. , Sufliarsky J., Beslija S., Saip P., Tulunay G., Krejcy K., et al.

GYNECOLOGIC ONCOLOGY, cilt.96, ss.374-380, 2005 (SCI İndekslerine Giren Dergi)

  • Cilt numarası: 96 Konu: 2
  • Basım Tarihi: 2005
  • Doi Numarası: 10.1016/j.ygyno.2004.10.011
  • Dergi Adı: GYNECOLOGIC ONCOLOGY
  • Sayfa Sayısı: ss.374-380

Özet

Objectives. Gemcitabine and carboplatin each have demonstrated effectiveness without increased neurotoxicity in pretreated patients with ovarian cancer. We evaluated the efficacy and safety of gemcitabine plus carboplatin in patients with recurrent ovarian cancer in a multicenter phase II study.